23rd Mar 2007 07:00
Cyprotex PLC23 March 2007 23 March, 2007 Cyprotex PLC (the "Company" or "Cyprotex") Requisitioned Extraordinary General Meeting On 6th March 2007, Cyprotex plc ("the Company") published a notice of anextraordinary general meeting ("the EGM") which had been requisitioned byProfessor David Leahy and Mr Robert Long ("the Requisitionists") to proposeresolutions to remove the current Directors ("the Board") and to appointthemselves plus two other nominees with immediate effect ("the Requisition"). The EGM is convened for 2nd April 2007, at 10.30am at the offices of WedlakeBell, 52 Bedford Row, London WC1R 4LR. In the notice convening the EGM, the Board reported that it had receivedirrevocable undertakings to support them against the Requisition fromshareholders holding an aggregate of 26,280,942 shares which in turn represents18.96 per cent of the Company and non-binding indications of support fromshareholders holding an aggregate of a further 39,015,098 shares representing afurther 28.15 per cent of the Company. The Board is pleased to announce that it now holds irrevocable undertakings andproxies from shareholders (including the Board) holding in aggregate 62,646,096shares which in turn represents 45.208 per cent of the Company. A further announcement about the EGM will be made in due course. In the meantime, all shareholders should by now have received the notice of theEGM together with the form of proxy for use at the EGM. This form of proxy isthe form shareholders can use to have their say by voting on the resolutionscontained in the notice of EGM ("the Resolutions"). The Board is recommendingthat all shareholders vote against all Resolutions. By doing so, shareholderswill be supporting the Board and a large percentage of the Company'sshareholders. Forms of proxy should be completed and signed in accordance with theinstructions printed thereon and returned to Capita Registrars, Proxy ProcessingCentre, Telford Road, Bicester 0X26 4LD so as to arrive as soon as possible andin any event not later than 10.30am on Saturday 31st March 2007. Every shareholders vote is important and the Board welcomes the continuingsupport from all shareholders. For further information: Cyprotex PLCRobert Morrison Atwater, CEOTel: +44 1625 505 [email protected] or Russell GibbsTel: +44 1625 505 [email protected] Media Enquires: WMC CommunicationsCharlie Geller/Alex GloverTel: +44 (0)20 7930 [email protected] This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
CRX.L